Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fast Forward And Myelin Repair Foundation: Two Routes To New MS Drugs

This article was originally published in Start Up

Executive Summary

Despite the availability of new oral medicines, larger advances in MS remain elusive, especially for those with advanced MS. Two nonprofit groups, the National MS Society’s Fast Forward venture arm and the Myelin Repair Foundation, are thinking creatively in different ways – but both spending millions of dollars – to make those breakthroughs come sooner.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

SC092297

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel